Science Explorer Back to mapMap
Discussion
Company · West Chester · United States

Molecular Targeting Technologies (United States)

mtarget.comROR OpenAlex
Research works
39
▼ 63% vs 2018-21
Citations
652
16.6 per fractional work
Top-10% rate
5.2%
all institutions 10.0%
Open access
36%
world 40%
International
22%
world 18%
Molecular Targeting Technologies (United States)

Not ranked overall: Molecular Targeting Technologies (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Molecular Targeting Technologies (United States) work in?

In all years, 43% of research at Molecular Targeting Technologies (United States) is in Health Sciences, 38% in Life Sciences. Its largest fields are Medicine (42%), Biochemistry, Genetics and Molecular Biology (25%), Immunology and Microbiology (11%). It does 2.0× the world's share of Life Sciences.

Health Sciences: 17 fractional works · 42.8% of its workMedicine: 17 fractional works · 42.4% of its workRadiology, Nuclear Medicine and Imaging: 7 fractional works · 18.5% of its workOncology: 3 fractional works · 7.1% of its workEpidemiology: 1 fractional works · 2.5% of its workSurgery: 1 fractional works · 2.2% of its workPulmonary and Respiratory Medicine: 1 fractional works · 2.1% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 1.6% of its workImmunology and Allergy: 1 fractional works · 1.5% of its workPharmacology: 1 fractional works · 1.5% of its workPathology and Forensic Medicine: 0 fractional works · 1.1% of its workInfectious Diseases: 0 fractional works · 0.8% of its workOphthalmology: 0 fractional works · 0.8% of its workNeurology: 0 fractional works · 0.8% of its workRheumatology: 0 fractional works · 0.5% of its workGenetics: 0 fractional works · 0.3% of its workHematology: 0 fractional works · 0.3% of its workNephrology: 0 fractional works · 0.2% of its workPhysiology: 0 fractional works · 0.2% of its workReproductive Medicine: 0 fractional works · 0.2% of its workNursing: 0 fractional works · 0.4% of its workNutrition and Dietetics: 0 fractional works · 0.4% of its workLife Sciences: 15 fractional works · 38.1% of its workBiochemistry, Genetics and Molecular Biology: 10 fractional works · 25.3% of its workMolecular Biology: 6 fractional works · 14.7% of its workBiotechnology: 1 fractional works · 3.2% of its workGenetics: 1 fractional works · 2.6% of its workCancer Research: 1 fractional works · 2.5% of its workBiophysics: 1 fractional works · 2.0% of its workCell Biology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workImmunology and Microbiology: 4 fractional works · 11.1% of its workImmunology: 2 fractional works · 6.2% of its workVirology: 2 fractional works · 4.0% of its workMicrobiology: 0 fractional works · 0.9% of its workAgricultural and Biological Sciences: 0 fractional works · 0.8% of its workAgronomy and Crop Science: 0 fractional works · 0.4% of its workAnimal Science and Zoology: 0 fractional works · 0.4% of its workNeuroscience: 0 fractional works · 0.8% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.6% of its workNeurology: 0 fractional works · 0.3% of its workPhysical Sciences: 7 fractional works · 17.2% of its workEngineering: 3 fractional works · 8.0% of its workBiomedical Engineering: 3 fractional works · 7.1% of its workAerospace Engineering: 0 fractional works · 0.8% of its workMaterials Science: 2 fractional works · 4.6% of its workBiomaterials: 1 fractional works · 3.5% of its workMaterials Chemistry: 0 fractional works · 1.1% of its workSmaller subfields together: 0 fractional works · 0.0% of its workChemistry: 1 fractional works · 3.4% of its workOrganic Chemistry: 1 fractional works · 2.6% of its workSpectroscopy: 0 fractional works · 0.8% of its workMathematics: 0 fractional works · 1.1% of its workStatistics and Probability: 0 fractional works · 1.1% of its workPhysics and Astronomy: 0 fractional works · 0.2% of its workSocial Sciences: 1 fractional works · 1.9% of its workSocial Sciences: 1 fractional works · 1.7% of its workSociology and Political Science: 0 fractional works · 0.8% of its workTransportation: 0 fractional works · 0.8% of its workSmaller subfields together: 0 fractional works · 0.0% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.2% of its workEconomics and Econometrics: 0 fractional works · 0.2% of its workALL ITS WORKMolecularTargeting…39fractional works, all years
Life Sciences38%Physical Sciences17%Health Sciences43%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 13 fields, with their numbers
    1. Medicine1742.4%
    2. Nursing00.4%
    1. Biochemistry, Genetics and Molecular Biology1025.3%
    2. Immunology and Microbiology411.1%
    3. Agricultural and Biological Sciences00.8%
    4. Neuroscience00.8%
    1. Engineering38.0%
    2. Materials Science24.6%
    3. Chemistry13.4%
    4. Mathematics01.1%
    5. Physics and Astronomy00.2%
    1. Social Sciences11.7%
    2. Economics, Econometrics and Finance00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Molecular Targeting Technologies (United States)?

Ranked on the quality score, Jeffrey A. Mattis, Koon Yan Pak and Brian D. Gray lead among researchers whose main affiliation is Molecular Targeting Technologies (United States).

  1. 1 Jeffrey A. Mattis United States · #1,166,071 worldwide 1.6k citations · 36 works
  2. 2 Koon Yan Pak United States · #7,002,836 worldwide 1.6k citations · 119 works
  3. 3 Brian D. Gray United States · #7,208,597 worldwide 1.5k citations · 119 works
All ranked researchers at Molecular Targeting Technologies (United States)

What are the most cited papers from Molecular Targeting Technologies (United States)?

The most cited paper from Molecular Targeting Technologies (United States) is "A Single Amino Acid Change in Rabies Virus Glycoprotein Increases Virus Spread and Enhances Virus Pathogenicity" (Milosz Faber, Marie-Luise Faber, Amy B. Papaneri et al., 2005), with 193 citations. Next come "The role of sensory organs and the forebrain for the development of the craniofacial shape as revealed by Foxg1‐cre‐mediated microRNA loss" (92) and "Biocompatible magnetic tris(2-aminoethyl)amine functionalized nanocrystalline cellulose as a novel nanocarrier for anticancer drug delivery of methotrexate" (86).

Most cited papers
#PaperReleasedCitations
1 A Single Amino Acid Change in Rabies Virus Glycoprotein Increases Virus Spread and Enhances Virus Pathogenicity Milosz Faber, Marie-Luise Faber, Amy B. Papaneri et al. · Journal of Virology Open access 27 Oct 2005 193
2 The role of sensory organs and the forebrain for the development of the craniofacial shape as revealed by Foxg1‐cre‐mediated microRNA loss Jennifer Kersigo, Alex d'Angelo, Brian D. Gray et al. · genesis Open access 10 Jan 2011 92
3 Biocompatible magnetic tris(2-aminoethyl)amine functionalized nanocrystalline cellulose as a novel nanocarrier for anticancer drug delivery of methotrexate Mahdi Rahimi, Salman Shojaei, Kazem Dindar Safa et al. · New Journal of Chemistry 2017 86
4 Very Early Noninvasive Detection of Acute Experimental Nonreperfused Myocardial Infarction With 99m Tc-Labeled Glucarate Jagat Narula, Artiom D. Petrov, Koon-Yan Pak et al. · Circulation 18 Mar 1997 75
5 Dominance of a Nonpathogenic Glycoprotein Gene over a Pathogenic Glycoprotein Gene in Rabies Virus Milosz Faber, Marie-Luise Faber, Jianwei Li et al. · Journal of Virology Open access 26 Apr 2007 62
All 61 most cited papers, with filters and sorting

Which keywords describe research at Molecular Targeting Technologies (United States)?

By fractional works in all years, weighted toward what it does more of than the world: PET Imaging, Reactive Oxygen Species, Tumor Targeting, Targeted Therapy, Cancer Treatment, Dosimetry, Radioimmunotherapy and Radiopharmaceuticals.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. PET Imaging5▲ 62×2 topics
  2. Reactive Oxygen Species5▲ 25×6 topics
  3. Tumor Targeting5▲ 91×3 topics
  4. Targeted Therapy4▲ 53×3 topics
  5. Cancer Treatment4▲ 44×3 topics
  6. Dosimetry4▲ 116×2 topics
  7. Radioimmunotherapy4▲ 265×1 topic
  8. Radiopharmaceuticals4▲ 265×1 topic
  9. Cancer4▲ 7.2×10 topics
  10. Immunotherapy4▲ 15×6 topics
  11. Cancer Therapy4▲ 15×3 topics
  12. Nanoparticles4▲ 7.2×3 topics
  13. Inflammation3▲ 3.1×13 topics
  14. Photodynamic Therapy3▲ 43×3 topics
  15. Gene Therapy2▲ 22×3 topics
  16. Fluorescence Imaging2▲ 51×1 topic
  17. Photothermal Therapy2▲ 67×1 topic
  18. Quantitative2▲ 46×2 topics
  19. Imaging2▲ 15×2 topics
  20. Macrophages2▲ 31×2 topics
  21. Apoptosis2▲ 13×4 topics
  22. Biomedical Applications2▲ 4.5×5 topics
  23. Angiogenesis2▲ 11×3 topics
  24. PET/CT2▲ 60×1 topic
  25. tumor2▲ 60×1 topic
  26. Pathogenesis2▲ 7.8×5 topics
  27. Tumor Microenvironment2▲ 12×2 topics
  28. Cancer Immunotherapy2▲ 28×2 topics
  29. CD472▲ 254×1 topic
  30. apoptotic cells2▲ 254×1 topic
  31. Bcl-2 Family1▲ 126×1 topic
  32. Cell Death1▲ 18×1 topic
  33. Drug Delivery1▲ 7.5×4 topics
  34. Gene Expression1▲ 5.9×6 topics
  35. Myocardial Infarction1▲ 13×4 topics
  36. Arginine Deprivation1▲ 72×1 topic
  37. Bacterial Therapy1▲ 72×1 topic
  38. Nanocarriers1▲ 72×1 topic
  39. Transmission1▲ 60×2 topics
  40. Virus1▲ 26×2 topics

Which research topics does Molecular Targeting Technologies (United States) publish most on?

By volume in 2022-now: Nanoplatforms for cancer theranostics, Radiopharmaceutical Chemistry and Applications, Neuroendocrine Tumor Research Advances and Lipid Membrane Structure and Behavior.

Nanoplatforms for cancer…0Nanoplatforms for cancer theranostics: 0 fractional worksRadiopharmaceutical Chem…0Radiopharmaceutical Chemistry and Applications: 0 fractional worksNeuroendocrine Tumor Research Advances: 0 fractional worksLipid Membrane Structure…0Lipid Membrane Structure and Behavior: 0 fractional worksLung Cancer Research Stu…0Lung Cancer Research Studies: 0 fractional worksMedical Imaging Techniqu…0Medical Imaging Techniques and Applications: 0 fractional worksCancer Research and Trea…0Cancer Research and Treatments: 0 fractional worksPhagocytosis and Immune …0Phagocytosis and Immune Regulation: 0 fractional worksCell Adhesion Molecules Research: 0 fractional worksNanoparticle-Based Drug Delivery: 0 fractional works
Biomedical EngineeringRadiology, Nuclear Medicine and ImagingEpidemiologyMolecular Biology5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Nanoplatforms for cancer theranostics Biomedical Engineering 0 works
  2. 2 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 0 works
  3. 3 Neuroendocrine Tumor Research Advances Epidemiology 0 works
  4. 4 Lipid Membrane Structure and Behavior Molecular Biology 0 works
  5. 5 Lung Cancer Research Studies Oncology 0 works
  6. 6 Medical Imaging Techniques and Applications Radiology, Nuclear Medicine and Imaging 0 works
  7. 7 Cancer Research and Treatments Biotechnology 0 works
  8. 8 Phagocytosis and Immune Regulation Immunology 0 works
  9. 9 Cell Adhesion Molecules Research Immunology and Allergy 0 works
  10. 10 Nanoparticle-Based Drug Delivery Biomaterials 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available36.3%not open63.7%

World: 40% of research is openly available.

with international co-authors21.9%domestic only78.1%

World: 18% is written across borders.

How has Molecular Targeting Technologies (United States)'s research output changed?

Output in 2022-2025 was 63% lower than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Molecular Targeting Technologies (United States) as a percentage of every work published that year, 0.000017% in 2024.

still counting0.000050%0.00010%0.00015%Molecular Targeting Technologies (United States)0.0000043% in 2025200020102020

Fractional works of Molecular Targeting Technologies (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in West Chester

All research institutions in West Chester

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Molecular Targeting Technologies (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.